|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 15264 |
FusionGeneSummary for GPR156_FSTL1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: GPR156_FSTL1 | Fusion gene ID: 15264 | Hgene | Tgene | Gene symbol | GPR156 | FSTL1 | Gene ID | 165829 | 11167 |
| Gene name | G protein-coupled receptor 156 | follistatin like 1 | |
| Synonyms | GABABL|PGR28 | FRP|FSL1|MIR198|OCC-1|OCC1|tsc36 | |
| Cytomap | 3q13.33 | 3q13.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | probable G-protein coupled receptor 156G protein-coupled receptor PGR28GABAB-related G-protein coupled receptor | follistatin-related protein 1follistatin-like protein 1 | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | Q8NFN8 | Q12841 | |
| Ensembl transtripts involved in fusion gene | ENST00000315843, ENST00000464295, ENST00000461057, | ENST00000295633, ENST00000424703, ENST00000485968, | |
| Fusion gene scores | * DoF score | 3 X 6 X 3=54 | 10 X 8 X 6=480 |
| # samples | 7 | 12 | |
| ** MAII score | log2(7/54*10)=0.374395514781498 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(12/480*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: GPR156 [Title/Abstract] AND FSTL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | UCEC | TCGA-KJ-A3U4-01A | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000315843 | ENST00000295633 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000315843 | ENST00000424703 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000315843 | ENST00000485968 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| In-frame | ENST00000464295 | ENST00000295633 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000464295 | ENST00000424703 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000464295 | ENST00000485968 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| Frame-shift | ENST00000461057 | ENST00000295633 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000461057 | ENST00000424703 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
| 5CDS-intron | ENST00000461057 | ENST00000485968 | GPR156 | chr3 | 119962487 | - | FSTL1 | chr3 | 120134874 | - |
Top |
FusionProtFeatures for GPR156_FSTL1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| GPR156 | FSTL1 |
| Orphan receptor. | May modulate the action of some growth factors on cellproliferation and differentiation. Binds heparin (By similarity).{ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GPR156_FSTL1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_GPR156_ENST00000464295_chr3_119962487_-_FSTL1_ENST00000295633_chr3_120134874_-_365aa MEPEINCSELCDSFPGQELDRRPLHDLCKTTITSSHHSSKTISSLSPVLLGIVWTFLSCGLLLILFFLAFTIHCRKNRKSXGANPRSVPM CFVEPAGNVQSQRKGNPPVSALSNANLTRGLCVAVMARPTSTTVNCIEMPASLDPKSRLITMDTAKRRNPXVHLPAQLFAISPTVMSSDV ASSSGWKLRSFQMAGSLKAATTVKSXTSILRTLIMVILAWTPVNSXSLWNRMKLPSILQRIQTRRTTSCLGDSVLMLSLNCLMKMLIGNS ASKSFSSASTHLSTLLRRSVPWRMKRMQMELRPRWTVTAVSVPVEIGSVQPXPVTERIRRGPRPRQRRRXPDMSRSSKSIRKQLKRPREX |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_GPR156_ENST00000464295_chr3_119962487_-_FSTL1_ENST00000295633_chr3_120134874_-_1097nt ATGGAGCCTGAAATAAACTGCTCTGAATTGTGTGACAGTTTTCCTGGCCAGGAGCTGGATCGGAGACCCCTTCATGATCTCTGCAAGACA ACAATTACATCTTCCCACCACAGCAGTAAGACCATCTCTTCATTATCTCCTGTCCTCTTGGGTATTGTTTGGACTTTTCTCAGCTGTGGA CTTCTGCTGATACTTTTCTTTCTTGCCTTTACAATTCACTGCAGGAAGAACAGGAAGAGCTAAGGAGCAAATCCAAGATCTGTGCCAATG TGTTTTGTGGAGCCGGCCGGGAATGTGCAGTCACAGAGAAAGGGGAACCCACCTGTCTCTGCATTGAGCAATGCAAACCTCACAAGAGGC CTGTGTGTGGCAGTAATGGCAAGACCTACCTCAACCACTGTGAACTGCATCGAGATGCCTGCCTCACTGGATCCAAAATCCAGGTTGATT ACGATGGACACTGCAAAGAGAAGAAATCCGTAAGTCCATCTGCCAGCCCAGTTGTTTGCTATCAGTCCAACCGTGATGAGCTCCGACGTC GCATCATCCAGTGGCTGGAAGCTGAGATCATTCCAGATGGCTGGTTCTCTAAAGGCAGCAACTACAGTGAAATCCTAGACAAGTATTTTA AGAACTTTGATAATGGTGATTCTCGCCTGGACTCCAGTGAATTCCTGAAGTTTGTGGAACAGAATGAAACTGCCATCAATATTACAACGT ATCCAGACCAGGAGAACAACAAGTTGCTTAGGGGACTCTGTGTTGATGCTCTCATTGAACTGTCTGATGAAAATGCTGATTGGAAACTCA GCTTCCAAGAGTTTCTCAAGTGCCTCAACCCATCTTTCAACCCTCCTGAGAAGAAGTGTGCCCTGGAGGATGAAACGTATGCAGATGGAG CTGAGACCGAGGTGGACTGTAACCGCTGTGTCTGTGCCTGTGGAAATTGGGTCTGTACAGCCATGACCTGTGACGGAAAGAATCAGAAGG GGGCCCAGACCCAGACAGAGGAGGAGATGACCAGATATGTCCAGGAGCTCCAAAAGCATCAGGAAACAGCTGAAAAGACCAAGAGAGTGA |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_GPR156_ENST00000464295_chr3_119962487_-_FSTL1_ENST00000295633_chr3_120134874_-_6202nt GGGGACCGTGGGCGTCCTGCACATAGCAGCGGGCTTGGCGCTTCTCGGCGGTCCGACGCTGATGAGGAACCAGAGTGAGGGTACTCGAAC AGTGACTGCCATCTGGTGGTTAACCAGAATCATCACCTTGTGTAGCCTGATGGTTACTAAGATGTCCACTCTTGACTCACATGGCATGCA CTCGCAGCAGGGGACCAGTTGAAGGATGTCTGACTTTGGAGGGTCACCAGTTGAAGGATGTCTGATGAAGGAGCCTAGCGAAATAACCCT TTGCTTCTACCTGAATGGGTTGTTCACTCTGGATTCTGAGCCTGCAGCCAGCTCCAAAATGGGGCCTCTGAAGAAAAGATTTGAGTTGCT CTTGTGTCTTAGTCAAAGATCTACATCCCTACCAGTGGGTAACCAAGACTGTGAATAAGCACACACCAACAGGGGCATGTGGTGACATGG AGCCTGAAATAAACTGCTCTGAATTGTGTGACAGTTTTCCTGGCCAGGAGCTGGATCGGAGACCCCTTCATGATCTCTGCAAGACAACAA TTACATCTTCCCACCACAGCAGTAAGACCATCTCTTCATTATCTCCTGTCCTCTTGGGTATTGTTTGGACTTTTCTCAGCTGTGGACTTC TGCTGATACTTTTCTTTCTTGCCTTTACAATTCACTGCAGGAAGAACAGGAAGAGCTAAGGAGCAAATCCAAGATCTGTGCCAATGTGTT TTGTGGAGCCGGCCGGGAATGTGCAGTCACAGAGAAAGGGGAACCCACCTGTCTCTGCATTGAGCAATGCAAACCTCACAAGAGGCCTGT GTGTGGCAGTAATGGCAAGACCTACCTCAACCACTGTGAACTGCATCGAGATGCCTGCCTCACTGGATCCAAAATCCAGGTTGATTACGA TGGACACTGCAAAGAGAAGAAATCCGTAAGTCCATCTGCCAGCCCAGTTGTTTGCTATCAGTCCAACCGTGATGAGCTCCGACGTCGCAT CATCCAGTGGCTGGAAGCTGAGATCATTCCAGATGGCTGGTTCTCTAAAGGCAGCAACTACAGTGAAATCCTAGACAAGTATTTTAAGAA CTTTGATAATGGTGATTCTCGCCTGGACTCCAGTGAATTCCTGAAGTTTGTGGAACAGAATGAAACTGCCATCAATATTACAACGTATCC AGACCAGGAGAACAACAAGTTGCTTAGGGGACTCTGTGTTGATGCTCTCATTGAACTGTCTGATGAAAATGCTGATTGGAAACTCAGCTT CCAAGAGTTTCTCAAGTGCCTCAACCCATCTTTCAACCCTCCTGAGAAGAAGTGTGCCCTGGAGGATGAAACGTATGCAGATGGAGCTGA GACCGAGGTGGACTGTAACCGCTGTGTCTGTGCCTGTGGAAATTGGGTCTGTACAGCCATGACCTGTGACGGAAAGAATCAGAAGGGGGC CCAGACCCAGACAGAGGAGGAGATGACCAGATATGTCCAGGAGCTCCAAAAGCATCAGGAAACAGCTGAAAAGACCAAGAGAGTGAGCAC CAAAGAGATCTAATGAGGAGGCACAGACCAGTGTCTGGATCCCAGCATCTTCTCCACTTCAGCGCTGAGTTCAGTATACACAAGTGTCTG CTACAGTCGCCAAATCACCAGTATTTGCTTATATAGCAATGAGTTTTATTTTGTTTATTTGTTTTGCAATAAAGGATATGAAGGTGGCTG GCTAGGAAGGGAAGGGCCACAGCCTTCATTTCTAGGAGTGCTTTAAGAGAAACTGTAAATGGTGCTCTGGGGCTGGAGGCTAGTAAGGAA ACTGCATCACGATTGAAAGAGGAACAGACCCAAATCTGAACCTCTTTTGAGTTTACTGCATCTGTCAGCAGGCTGCAGGGAGTGCACACG ATGCCAGAGAGAACTTAGCAGGGTGTCCCCGGAGGAGAGGTTTGGGAAGCTCCACGGAGAGGAACGCTCTCTGCTTCCAGCCTCTTTCCA TTGCCGTCAGCATGACAGACCTCCAGCATCCACGCATCTCTTGGTCCCAATAACTGCCTCTAGATACATAGCCATACTGCTAGTTAACCC AGTGTCCCTCAGACTTGGATGGAGTTTCTGGGAGGGTACACCCAAATGATGCAGATACTTGTATACTTTGAGCCCCTTAGCGACCTAACC AAATTTTAAAAATACTTTTTACCAAAGGTGCTATTTCTCTGTAAAACACTTTTTTTTGGCAAGTTGACTTTATTCTTCAATTATTATCAT TATATTATTGTTTTTTAATATTTTATTTTCTTGACTAGGTATTAAGCTTTTGTAATTATTTTTCAGTAGTCCCACCACTTCATAGGTGGA AGGAGTTTGGGGTTCTTCCTGGTGCAGGGGCTGAAATAACCCAGATGCCCCCACCCTGCCACATACTAGATGCAGCCCATAGTTGGCCCC CCTAGCTTCCAGCAGTCCACTATCTGCCAGAGGAGCAAGGGTGCCTTAGACCGAAGCCAGGGGAAGAAGCATCTTCATAAAAAACTTTCA AGATCCAAACATTAATTTGTTTTTATTTATTCTGAGAAGTTGAGGCAAATCAGTATTCCCAAGGATGGCGACAAGGGCAGCCAAGCAGGG CTTAGGATATCCCAGCCTACCAATATGCTCATTCGACTAACTAGGAGGGTGAGTTGGCCCTGTCTCTTCTTTTTTCTGGACCTCAGTTTC CTCAGTGAGCTGGTAAGAATGCACTAACCTTTTGATTTGATAAGTTATAAATTCTGTGGTTCTGATCATTGGTCCAGAGGGGAGATAGGT TCCTGTGATTTTTCCTTCTTCTCTATAGAATAAATGAAATCTTGTTACTAGAACAAGAAATGTCAGATGGCCAAAAACAAGATGACCAGA TTTGATCTCAGCCTGATGACCCTACAGGTCGTGCTATGATATGGAGTCCTCATGGGTAAAGCAGGAAGAGAGTGGGAAAGAGAACCACCC CACTCTGTCTTCATATTTGCATTTCATGTTTAACCTCCGGCTGGAAATAGAAAGCATTCCCTTAGAGATGAGGATAAAAGAAAGTTTCAG ATTCAACAGGGGGAAGAAAATGGAGATTTAATCCTAAAACTGTGACTTGGGGAGGTCAGTCATTTACAGTTAGTCCTGTGTCTTTCGACT TCTGTGATTATTAACCCCACTCACTACCCTGTTTCAGATGCATTTGGAATACCAAAGATTAAATCCTTGACATAAGATCTCATTTGCAGA AAGCAGATTAAAGACCATCAGAAGGAAATTATTTAGGTTGTAATGCACAGGCAACTGTGAGAAACTGTTGTGCCAAAAATAGAATTCCTT CTAGTTTTTCTTGTTCTCATTTGAAAGGAGAAAATTCCACTTTGTTTAGCATTTCAAGCTTTTATGTATCCATCCCATCTAAAAACTCTT CAAACTCCACTTGTTCAGTCTGAAATGCAGCTCCCTGTCCAAGTGCCTTGGAGAACTCACAGCAGCACGCCTTAATCAAAGGTTTTACCA GCCCTTGGACACTATGGGAGGAGGGCAAGAGTACACCAATTTGTTAAAAGCAAGAAACCACAGTGTCTCTTCACTAGTCATTTAGAACAT GGTTATCATCCAAGACTACTCTACCCTGCAACATTGAACTCCCAAGAGCAAATCCACATTCCTCTTGAGTTCTGCAGCTTCTGTGTAAAT AGGGCAGCTGTCGTCTATGCCGTAGAATCACATGATCTGAGGACCATTCATGGAAGCTGCTAAATAGCCTAGTCTGGGGAGTCTTCCATA AAGTTTTGCATGGAGCAAACAAACAGGATTAAACTAGGTTTGGTTCCTTCAGCCCTCTAAAAGCATAGGGCTTAGCCTGCAGGCTTCCTT GGGCTTTCTCTGTGTGTGTAGTTTTGTAAACACTATAGCATCTGTTAAGATCCAGTGTCCATGGAAACATTCCCACATGCCGTGACTCTG GACTATATCAGTTTTTGGAAAGCAGGGTTCCTCTGCCTGCTAACAAGCCCACGTGGACCAGTCTGAATGTCTTTCCTTTACACCTATGTT TTTAAGTAGTCAAACTTCAAGAAACAATCTAAACAAGTTTCTGTTGCATATGTGTTTGTGAACTTGTATTTGTATTTAGTAGGCTTCTAT ATTGCATTTAACTTGTTTTTGTAACTCCTGATTCTTCCTTTTCGGATACTATTGATGAATAAAGAAATTAAAGTGATGGTTTTATTGGTT TCCTTTCCCCCAATTAAGGCCAAATAAAGTCGTGAGAACATTACCCATTTACTTCCTAAGAGTGGATTTGAGTTTCAGGAGCCTTAAAAA GGACTGAAGAGTTTCTCCTGGGACTACAGCTTGGATGGAAAGTTTACTCGGGGACTGGTAGAACAAGTTTCTTTGAAAGGATCATGGATA GTGGGTCTGGAGTAGAAGGTGATGACAAGTCAGAAAGTGTCTTAGTCCCTTCAAGTTGCTATAACAAAATGCCTCAGACTGGGTAATTAT AGGCAACAGAAATGTATTGCTCACAGTTCTGAAGGCTGGGAAGCCTAAGATCAAGGTACCAGCAGATTCAGTGTCTGATGACGGCTTGTT GAAGCTTGCCTGCTTCAAAGAATGCACCTTTTTGATGCATCCCCACATGGTGAAAAGGGTGAACAAACTCCCTTAGGCCTCTTTTATAAG GGCACTTACCCATTCATGAGGGTTAAACTTTGATGACCTAATCATCTCCCAAGAGCCTCACCTCTCAATACCATTGCTTTGGGGATTCAA TTTTAACATATGAATTTTGGGGGACATAAACATTCAAACCATAGCAGGTGCATTCCTGTATTGGGAAGACATTAAATTAAATGACTCGTA AATCCCCCATATGATTTAGGAGACTAAATGGCATCCAGTGAGGCTGACTGCAGTAGCCTGTGAGAAGGCAAATAAACATGGGAAGGTAGT ACAGGGAACATGGAATCATTGCCAGGGACAGGCTAAATAACCTTAATGGCACTTCCTTGATACACACATTCCATGGGGGTAAACAGTTCC AAGTGGGCTGAACGTTAGCTGGTTAAAACCTCTTTTGCTTGGGGACACATGACTAACGCTTTCCAACCTGCCATTTTCATATGTATCATG CACTCTCCACCCACAATAATTCTGCCTCCCAAAAGAGCATATTATAGTCAATGAGGTTTAAGGTTTCTTCGGTTCAGTCATGTGGAAGTT TTGCTTTCCTAAAATTATAGCTGGATCACTTTGATTGGATTTGGGATATTACCCAAATGCTAATCAAATATTAAAAGGCAATCTTTTTTG TTATGTGATTGCTACAGATTACTGCTCTTACAGTTTGATTCTTCAAATTTTCATTCTCAGAAGGGAATCTTAAACCCAGTTTGAAGGGTA CCTTGTCCACAACCACTTTTAAATTTTGGCTAACTTCCCAACCTTCCACCATGTTCTGGGAAAACTTTTTCTGCTGTTATAGTATGTATG TATTCAGGAAGTGCAACATTATTAAACTAAGCATAATTCAGAAGCTAAGTTTCCTTTCATCAAAATTTAATATTACGAATTGTGCAAAGA AGTATGTTACTTTGATCAGCTTTATTTTAGAGCTTCTTTATCAAGTTATCATCAGTCCTCTTGAATTATTTCTGAAATAAGGGGAAGGAA GGAAGGGAAAAAATATGAATGCATAGATAGATCTAAGCAGATGCCTTCAGAGCCCTGGAATAATCCTAGCTGGGATATGGGACATGAAAA CAACTCTGGCCTACTGCTGCTGGGGGCTGTTGCATGGTGTGACATAGGAAGTAAAATGTTGCTGTATGAATAGGAAGGAGGGTCTTCCTG TCAATGAGAATTAATGTTTTCCTAATGATTTAACTTTTTTACTGAAAAAATAATATGTGTACATGGTAAAAATCCAAATTGTATCACAGA AAATACAGTGAATAAAACCATCCTCTTAAGAGGGTGTGTACATTTATAAATTTGCCTATGATTGCCTATAAAGTCAAAGAAGTTGCACCA GTATGCATGACTGCCAAAAGTACATAAACTGAGCATATCCATTTCCCTACATTCTTGCAAACATTGTGCCTTCGAACTTTTTGGCCTCTG |
Top |
FusionGenePPI for GPR156_FSTL1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| GPR156 | ZNF564, RPUSD2, VANGL2, VANGL1, ZBTB1, ZNF444, NFKBIL1, AGAP3, PLD1, FARP2, SHQ1, MCRS1, PHTF2, PPP2R3B, OBSL1, KANSL2, SNX33, ZMYM1, SNX27, ANAPC4, SULF2, ANAPC5, PER1, KAT5, PLCD3, AP2A1, MAPK14, AP1B1, ANAPC1, CDC23, AMPD2, PHTF1, PIP5K1A, PRKCI, AP2A2, ZNF460, CDC16, TYK2, PLD2, PRKRIR, NOS1AP, TIFA, ACAD11, ECD, TSSC4, PEX14, CSNK1G3, AP2M1, SLC4A7, TRAF7, SCML1, PDCD2L, PHLDB3, ZNHIT2, STX8, TP53, TYW1, ARRB2, SNRNP200, ZNF627, PRPF6, JPH1, RNF138, ZNF696, ZNF574, ZZEF1, PRPF8, POLR2A, GTF3C1 | FSTL1 | APPBP2, DNASE2B, SGCA, WNT10B, CRK, GPR114, IL12A, LYZL2, LRRC4C, PRG3, WNT4, ADAM33, FBXO6, FBXL14, WNT5A, WNT7A, SCGB1D2, TM2D3, PRELP, INSL6, DEFA1, ZPBP2, CHST8, SCGB2A2, DEFB121, XCL1, MTNR1A, MTNR1B |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GPR156_FSTL1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for GPR156_FSTL1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | FSTL1 | C0003504 | Aortic Valve Insufficiency | 1 | CTD_human |
| Tgene | FSTL1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | FSTL1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Tgene | FSTL1 | C0043094 | Weight Gain | 1 | CTD_human |
| Tgene | FSTL1 | C2609414 | Acute kidney injury | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|